https://iro.uiowa.edu/esploro/outputs/journalArticle/Practical-Considerations-for-Infection-Prevention-With/9985139495502771?institution=01IOWA_INST&skipUsageReporting=true&recordUsage=false
Practical Considerations for Infection Prevention With the Clinical Use of Complement Inhibitors -...
Overactivation of the complement system plays a role in the pathophysiology of several serious kidney diseases, such as immunoglobulin A nephropathy,...
practical considerationsinfection preventionclinical usecomplement inhibitors
https://www.hcsp.fr/hcspi/Explore.cgi/avisrapportsdomaine?clefr=1204
Prevention of invasive infections in patients treated with complement inhibitors
in patientscomplement inhibitorspreventioninvasiveinfections
https://www.precedenceresearch.com/c5-complement-inhibitors-market
C5 Complement Inhibitors Market Size to Hit USD 16.01 Billion by 2034
The global C5 complement inhibitors market size is estimated to hit around USD 16.01 billion by 2034 increasing from USD 4.25 billion in 2024, with a CAGR of...
complement inhibitorsmarket sizehitusdbillion
https://researchconnect.buffalo.edu/en/publications/complement-inhibitors-targeted-to-the-proximal-tubule-prevent-inj/
Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic...
complement inhibitorstargetedproximaltubuleprevent
https://www.cdc.gov/meningococcal/risk-factors/receiving-complement-inhibitors.html
Meningococcal Disease and People Receiving Complement Inhibitors | Meningococcal | CDC
People who take complement inhibitors are at increased risk for meningococcal disease.
meningococcal diseasecomplement inhibitorspeoplereceivingcdc
https://www.eyenews.uk.com/features/ophthalmology/post/emerging-therapies-for-geographic-atrophy-complement-inhibitors-show-potential-to-slow-progression-and-preserve-rpe-and-photoreceptor-integrity
Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression...
emerging therapiesgeographic atrophycomplement inhibitorsshowpotential